IA
IMUC

IFP Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

IFP Advisors’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$0 Hold
95
– – ﹤0.01% 4013
2018
Q4 		$0 Hold
95
– – ﹤0.01% 4141
2018
Q3 		$0 Hold
95
– – ﹤0.01% 4198
2018
Q2 		$0 Hold
95
– – ﹤0.01% 4281
2018
Q1 		$0 Hold
95
– – ﹤0.01% 3936
2017
Q4 		$0 Hold
95
– – ﹤0.01% 4423
2017
Q3 		$0 Hold
95
– – ﹤0.01% 4419
2017
Q2 		$0 Hold
95
– – ﹤0.01% 4413
2017
Q1 		$0 Buy
+95
New +$248 ﹤0.01% 4354
2016
Q2 		– Sell
-2
Closed – – 4327
2016
Q1 		$0 Sell
2
-53
-96% -$596 ﹤0.01% 4461
2015
Q4 		$1K Buy
+55
New +$909 ﹤0.01% 3686

IFP Advisors's IMUC Position: Q1 2019 in Review

IFP Advisors held its ImmunoCellular Therapeutics, Ltd. (IMUC) position steady in Q1 2019 at 95 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4013.

IFP Advisors first reported a position in IMUC in Q4 2015 and has held it in 11 quarters since. The position peaked at $1K in Q4 2015. 1 fund tracked by Wall St. Rank holds IMUC as of Q1 2019.

  • IFP Advisors held 95 shares of ImmunoCellular Therapeutics, Ltd. worth $0 as of Q1 2019.
  • IFP Advisors left its ImmunoCellular Therapeutics, Ltd. share count unchanged in Q1 2019.
  • ImmunoCellular Therapeutics, Ltd. made up ﹤0.01% of IFP Advisors's portfolio in Q1 2019, its #4013 holding.
  • IFP Advisors first reported a position in ImmunoCellular Therapeutics, Ltd. in Q4 2015 and has held it in 11 quarters since.
  • IFP Advisors's ImmunoCellular Therapeutics, Ltd. position peaked at $1K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.